Search
for
Sort by
Research 331–360 of 1000+
- Renbök Phenomenon in a Patient With Alopecia Areata Universalis
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- Alopecia Areata Is Associated with Posttraumatic Stress Disorder and Alcohol Use in a Case-Control Study of 4,785 Patients
- Clinical and demographic characteristics associated with nail involvement in alopecia areata: A cross‐sectional study of 197 patients
- Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
- HR Gene Variants Identified in Mexican Patients with Alopecia Areata
- Serum brain‐derived neurotrophic factor and vitamin D: Two concordant players controlling depression among alopecia areata and vitiligo patients: A case–control study
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata
- Alopecia areata possibly induced by autoimmune reaction in a patient with human T‐cell lymphotropic virus‐1‐associated myelopathy
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Anxiety and Depression in Patients with Alopecia Areata in Eskisehir, Turkey
- Dietary Habits in Japanese Patients with Alopecia Areata
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Efficacy and safety of baricitinib in patients with refractory alopecia areata
- Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States
- Spontaneous hair regrowth in eight patients with severe alopecia areata
- Thyroid Disease in Alopecia Areata, Lichen Planopilaris, and Frontal Fibrosing Alopecia—A Case Control Study of 144 Patients
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles
- Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
- Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies
- Effective Role of Cytotoxic CD8+ T Cell in Iraqi Alopecia areata Patients
- Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
- Social Media Use in Patients with Alopecia Areata
- Increase in IL-15 levels in patients with alopecia areata
- Stressful lie events in alopecia areata patients: A case control study